LARYNGEAL SQUAMOUS CELL CARCINOMA

This adverse event was reported 108 times

LARYNGEAL SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 1 0.0007
1 GIVOSIRAN SODIUM 1 0.0006
2 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
3 GOLIMUMAB 5 0.0004
4 ELOTUZUMAB 2 0.0004
5 TAFLUPROST 1 0.0003
6 NALOXEGOL OXALATE 1 0.0003
7 TIOTROPIUM BROMIDE AND OLODATEROL 1 0.0002
8 RALTEGRAVIR 1 0.0002
9 TASIMELTEON 1 0.0002
See all drugs enriched for association with LARYNGEAL SQUAMOUS CELL CARCINOMA